ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation

Sheng, Xiaoli; Liu, Wenlin; Lu, Zhongming; Xu, Mimi; Li, Rui; Zhong, Rong; Li, Yunxian; Liu, Tao*; Zhang, Siyi*广东省人民医院; 广州医学院; 南方医科大学; 汕头大学; 6
Annals of Translational Medicine2021-5DOI: 10.21037/atm-21-1069
5被引5阅读
引用收藏
分享

摘要

Background: Laryngeal cancer is a common malignancy of the head and neck, it's important to find novel targets for its therapy. The 5-hydroxytryptamine receptor 7 (HTR7) belongs to the G protein-coupled receptors (GPCRs) family which are easily druggable in diseases; however, its role in laryngeal cancer remains unknown. @@@ Methods: Colony formation assay, Soft agar growth assay, BrdU incorporation assay and MTT assay were used to analyze the effect of HTR7 on laryngeal cancer cell proliferation. Xenograft tumors in nude mice was used to analyze the effect of HTR7 on laryngeal cancer growth. Luciferase reporter assay was used to analyze the effect of HTR7 on phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/protein kinase B (AKT) pathway activity. @@@ Results: We found that HTR7 was significantly upregulated in laryngeal cancer tissues and cells, and patients with high HTR7 expression had shorter survival time than those with low HTR7 expression. Univariate and multivariate Cox regression models showed that HTR7 was an independent predictive factor for the prognosis of patients with laryngeal cancer. Cell proliferation assays and an animal model showed that HTR7 overexpression promoted laryngeal cancer proliferation and growth, while HTR7 knockdown inhibited laryngeal cancer proliferation and growth. Further analysis showed HTR7 activated the PI3K/AKT pathway, characterized by increased phosphorylation of AKT, luciferase reporter activity of forkhead box O (FOXO) factors, and target expression. Inhibition of the PI3K/AKT pathway in HTR7-overexpressing cells suppressed proliferation and growth, suggesting that HTR7 promotes laryngeal cancer proliferation and growth by activating the PI3K/AKT pathway. @@@ Conclusions: HTR7 is not only a target for laryngeal cancer therapy but also a prognostic factor for the prognosis of patients with laryngeal cancer.

学科与关键词

关键词
5-hydroxytryptamine receptor 7laryngeal cancerprotein kinase B (AKT)tumor growth
相关
加载中…
  • Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway
    Liu, Wenlin; Zhan, Jiandong; Zhong, Rong; Li, Rui; Sheng, Xiaoli; Xu, Mimi; Lu, Zhongming; Zhang, Siyi*TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20: 1533033821990074.被引 12
  • Deriving prognostic significance from a molecular subtype model of laryngeal carcinoma
    Zhou, Yibo; Wang, Jiahong; Huang, Zhongxi; Gong, Pinggui; Xie, Minqiang*Head and Neck, 2022, 44(10): 2206-2219.
  • HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K/AKT/FOXO1
    Li, Fei; Xie, Weiwei; Fang, Yunze; Xie, Kunfeng; Liu, Wendong; Hou, Lina*; Tan, Wanlong*American Journal of Cancer Research, 2021, 12(1): 281-291.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2021-05
卷期
第 9 卷, 第 10 期
页码
840
DOI
10.21037/atm-21-1069
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province, China [2019A1515011678]

作者

  • S

    Sheng, Xiaoli (第一作者)

    guangdong prov peoples hosp · 2 · southern med univ

  • L

    Liu, Wenlin

    2 · southern med univ · 6 · guangzhou med univ

查看全部 9 位作者收起作者
  • L

    Lu, Zhongming

    guangdong prov peoples hosp · 2 · southern med univ

  • X

    Xu, Mimi

    guangdong prov peoples hosp

  • L

    Li, Rui

    guangdong prov peoples hosp

  • Z

    Zhong, Rong

    guangdong prov peoples hosp

  • L

    Li, Yunxian

    guangdong prov peoples hosp · shantou univ

  • L

    Liu, Tao (通讯)

    guangdong prov peoples hosp

  • Z

    Zhang, Siyi (通讯)

    guangdong prov peoples hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417